Literature DB >> 3364956

National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria.

W J Brown1.   

Abstract

One hundred nine recent clinical isolates of anaerobic gram-negative bacteria were tested in triplicate by the National Committee for Clinical Laboratory Standards agar dilution procedure for their susceptibility to 32 antimicrobial agents. All isolates were inhibited by imipenem, but there were significant numbers of strains resistant to other beta-lactam drugs, and therefore the in vitro response to these antimicrobial agents cannot be predicted. This was particularly true for the bile-resistant or Bacteroides fragilis group. beta-Lactamase production was detected in 82% of the bacteroides with the nitrocefin test. Clavulanic acid combined with amoxicillin and ticarcillin and sulbactam combined with ampicillin resulted in synergistic activity against all beta-lactamase-positive organisms. Ceftizoxime was the most active of the cephalosporins. Two percent of the isolates were resistant to chloramphenicol and metronidazole. Clindamycin resistance was detected in 38% of the B. fragilis group, which is a marked increase from the 4% detected 10 years ago at this institution.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3364956      PMCID: PMC172181          DOI: 10.1128/AAC.32.3.385

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  beta-Lactamases of subspecies of Bacteroides fragilis.

Authors:  T Leung; J D Williams
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

2.  The activity of five cephalosporins against Bacteroides fragilis.

Authors:  R W Ryan; I Kwasnik; R C Tilton
Journal:  Ann Clin Lab Sci       Date:  1982 Jan-Feb       Impact factor: 1.256

3.  In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins.

Authors:  A W Chow; S M Finegold
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

4.  Susceptibility testing of clinically isolated anaerobic bacteria by an agar dilution technique.

Authors:  W J Brown; P E Waatti
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

5.  In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteria.

Authors:  V L Sutter; B Kirby; S M Finegold
Journal:  Rev Infect Dis       Date:  1979 Jan-Feb

Review 6.  Antimicrobial susceptibility testing of anaerobic bacteria.

Authors:  J E Rosenblatt
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

7.  Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.

Authors:  T Kesado; K Watanabe; Y Asahi; M Isono; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  Variability in the susceptibility pattern of Bacteroides fragilis in four Detroit area hospitals.

Authors:  R E Bawdon; E Rozmiej; S Palchaudhuri; J Krakowiak
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

9.  In vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzylpenicillin, cephalothin, and cefoxitin.

Authors:  A Eley; D Greenwood
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

10.  In vitro activity of azthreonam, a monobactam antibiotic.

Authors:  N V Jacobus; M C Ferreira; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

View more
  11 in total

1.  Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole.

Authors:  J A Bosso; R A Prince
Journal:  Tex Heart Inst J       Date:  1990

2.  Spiral gradient endpoint method compared to standard agar dilution for susceptibility testing of anaerobic gram-negative bacilli.

Authors:  G B Hill
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

3.  Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.

Authors:  M R Jacobs; S K Spangler; P C Appelbaum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-06       Impact factor: 3.267

Review 4.  Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

Authors: 
Journal:  CMAJ       Date:  1990-06-01       Impact factor: 8.262

5.  Selection of constitutively resistant mutants of inducible clindamycin-resistant Bacteroides vulgatus.

Authors:  M Reig; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

6.  Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

7.  Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria.

Authors:  R A Venezia; D M Yocum; E M Robbiano; R M Echols
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

8.  Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  Comparative in vitro antimicrobial susceptibilities of a special panel of 74 Bacteroides fragilis group isolates in Wilkins-Chalgren agar with and without sheep blood.

Authors:  C J Gill; D L Shungu; S Ponticas
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

10.  Evaluation of two methods for rapid testing for beta-lactamase production in Bacteroides and Fusobacterium.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.